ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ceRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone

Published:2020-10 Issue: Volume:24 Page:100304
ISSN:2212-1374
Container-title:Journal of Bone Oncology
language:en
Short-container-title:Journal of Bone Oncology

Author:

Liu Shuzhong,Song An,Zhou Xi,Huo Zhen,Yao Siyuan,Yang Bo,Liu Yong,Wang Yipeng

Funder

National Natural Science Foundation of China

Peking Union Medical College Graduate Student Innovation Fund

Publisher

Elsevier BV

Subject

Oncology

Reference48 articles.

1. Breast cancer statistics, 2019;DeSantis;CA A Cancer J. Clin.,2019

2. Bone metastases: Pathophysiology and management policy;Nielsen;J. Clin. Oncol.,1991

3. Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status;Hayashi;J. Cancer,2017

4. ER+/HER2+ breast cancer has different metastatic patterns and better survival than ER−/HER2+ breast cancer;Arciero;Clin. Breast Cancer.,2019

5. Novel microRNA-based risk score identified by integrated analyses to predict metastasis and poor prognosis in breast cancer;Kawaguchi;Ann. Surg. Oncol.,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC);International Journal of Molecular Sciences;2024-02-23

2. BZDRs promote breast cancer progression through GABRA3-ECM signaling;2024-02-12

3. The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma;Open Medicine;2024-01-01

4. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer;International Journal of Molecular Sciences;2023-09-06

5. The current advances of lncRNAs in breast cancer immunobiology research;Frontiers in Immunology;2023-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3